CRSP logo

CRISPR Therapeutics AG (CRSP) Revenue

Annual revenue:

$35.00M-$335.00M(-90.54%)
December 31, 2024

Summary

  • As of today (May 9, 2025), CRSP annual revenue is $35.00 million, with the most recent change of -$335.00 million (-90.54%) on December 31, 2024.
  • During the last 3 years, CRSP annual revenue has fallen by -$878.08 million (-96.17%).
  • CRSP annual revenue is now -96.17% below its all-time high of $913.08 million, reached on December 31, 2021.

Performance

CRSP Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCRSPincome statement metrics

Quarterly revenue:

$0.00-$35.00M(-100.00%)
March 31, 2025

Summary

  • As of today (May 9, 2025), CRSP quarterly revenue is $0.00, with the most recent change of -$35.00 million (-100.00%) on March 31, 2025.
  • CRSP quarterly revenue is now -100.00% below its all-time high of $900.20 million, reached on June 30, 2021.

Performance

CRSP Quarterly revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCRSPincome statement metrics

TTM revenue:

$35.00M$0.00(0.00%)
March 31, 2025

Summary

  • As of today (May 9, 2025), CRSP TTM revenue is $35.00 million, unchanged on March 31, 2025.
  • CRSP TTM revenue is now -96.17% below its all-time high of $913.08 million, reached on December 31, 2021.

Performance

CRSP TTM revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCRSPincome statement metrics

CRSP Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-90.5%--
3 y3 years-96.2%-100.0%-96.2%
5 y5 years-87.9%-100.0%-87.9%

CRSP Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-96.2%+7927.5%-100.0%at low-96.2%+7927.5%
5 y5-year-96.2%+7927.5%-100.0%at low-96.2%+7927.5%
alltimeall time-96.2%>+9999.0%-100.0%at low-96.2%>+9999.0%

CRSP Revenue History

DateAnnualQuarterlyTTM
Mar 2025
-
$0.00(-100.0%)
$35.00M(0.0%)
Dec 2024
$35.00M(-90.5%)
$35.00M(-82.5%)
$35.00M(-90.5%)
Dec 2023
$370.00M(>+9900.0%)
$200.00M(+185.7%)
$370.00M(+117.5%)
Jun 2023
-
$70.00M(-30.0%)
$170.10M(+69.7%)
Mar 2023
-
$100.00M(>+9900.0%)
$100.26M(>+9900.0%)
Dec 2022
$436.00K(-100.0%)
$6000.00(-93.6%)
$436.00K(-96.6%)
Sep 2022
-
$94.00K(-40.5%)
$12.78M(-1.8%)
Jun 2022
-
$158.00K(-11.2%)
$13.01M(-98.6%)
Mar 2022
-
$178.00K(-98.6%)
$913.06M(-0.0%)
Dec 2021
$913.08M(>+9900.0%)
$12.35M(+3653.2%)
$913.08M(+1.3%)
Sep 2021
-
$329.00K(-100.0%)
$900.93M(+0.0%)
Jun 2021
-
$900.20M(>+9900.0%)
$900.75M(>+9900.0%)
Mar 2021
-
$202.00K(+4.1%)
$588.00K(+8.3%)
Dec 2020
$543.00K(-99.8%)
$194.00K(+31.1%)
$543.00K(-99.3%)
Sep 2020
-
$148.00K(+236.4%)
$77.36M(-73.2%)
Jun 2020
-
$44.00K(-72.0%)
$289.14M(-0.1%)
Mar 2020
-
$157.00K(-99.8%)
$289.42M(-0.1%)
DateAnnualQuarterlyTTM
Dec 2019
$289.59M(+9169.8%)
$77.02M(-63.7%)
$289.59M(+36.2%)
Sep 2019
-
$211.93M(>+9900.0%)
$212.69M(>+9900.0%)
Jun 2019
-
$318.00K(-3.0%)
$1.32M(-36.8%)
Mar 2019
-
$328.00K(+185.2%)
$2.09M(-33.0%)
Dec 2018
$3.12M(-92.4%)
$115.00K(-79.6%)
$3.12M(-91.2%)
Sep 2018
-
$563.00K(-48.3%)
$35.33M(-4.9%)
Jun 2018
-
$1.09M(-19.9%)
$37.16M(-6.3%)
Mar 2018
-
$1.36M(-95.8%)
$39.65M(-3.3%)
Dec 2017
$41.00M(+693.9%)
$32.33M(+1254.2%)
$41.00M(+272.2%)
Sep 2017
-
$2.39M(-33.4%)
$11.02M(+8.2%)
Jun 2017
-
$3.58M(+32.5%)
$10.18M(+37.7%)
Mar 2017
-
$2.70M(+15.3%)
$7.39M(+43.1%)
Dec 2016
$5.16M(+1990.7%)
$2.34M(+51.3%)
$5.16M(+68.4%)
Sep 2016
-
$1.55M(+94.8%)
$3.07M(+102.0%)
Jun 2016
-
$795.00K(+67.0%)
$1.52M(+110.0%)
Mar 2016
-
$476.00K(+92.7%)
$723.00K(+192.7%)
Dec 2015
$247.00K
$247.00K
$247.00K

FAQ

  • What is CRISPR Therapeutics AG annual revenue?
  • What is the all time high annual revenue for CRISPR Therapeutics AG?
  • What is CRISPR Therapeutics AG annual revenue year-on-year change?
  • What is CRISPR Therapeutics AG quarterly revenue?
  • What is the all time high quarterly revenue for CRISPR Therapeutics AG?
  • What is CRISPR Therapeutics AG TTM revenue?
  • What is the all time high TTM revenue for CRISPR Therapeutics AG?

What is CRISPR Therapeutics AG annual revenue?

The current annual revenue of CRSP is $35.00M

What is the all time high annual revenue for CRISPR Therapeutics AG?

CRISPR Therapeutics AG all-time high annual revenue is $913.08M

What is CRISPR Therapeutics AG annual revenue year-on-year change?

Over the past year, CRSP annual revenue has changed by -$335.00M (-90.54%)

What is CRISPR Therapeutics AG quarterly revenue?

The current quarterly revenue of CRSP is $0.00

What is the all time high quarterly revenue for CRISPR Therapeutics AG?

CRISPR Therapeutics AG all-time high quarterly revenue is $900.20M

What is CRISPR Therapeutics AG TTM revenue?

The current TTM revenue of CRSP is $35.00M

What is the all time high TTM revenue for CRISPR Therapeutics AG?

CRISPR Therapeutics AG all-time high TTM revenue is $913.08M
On this page